These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 6283325

  • 21. Autonomic innervation of human airways: structure, function, and pathophysiology in asthma.
    van der Velden VH, Hulsmann AR.
    Neuroimmunomodulation; 1999; 6(3):145-59. PubMed ID: 10213912
    [Abstract] [Full Text] [Related]

  • 22. Studies on the causes of asthmatic dyspnea. (The cybernetic theory of bronchial asthma).
    Farrerons-Co J.
    Allergol Immunopathol (Madr); 1982; 10(2):137-46. PubMed ID: 6285683
    [No Abstract] [Full Text] [Related]

  • 23. Upper respiratory tract infections and airway reactivity in normal and asthmatic subjects.
    Jenkins CR, Breslin AB.
    Am Rev Respir Dis; 1984 Nov; 130(5):879-83. PubMed ID: 6497166
    [Abstract] [Full Text] [Related]

  • 24. Neurogenic and myogenic mechanisms of nonspecific bronchial hyperresponsiveness.
    Thomson NC.
    Eur J Respir Dis Suppl; 1983 Nov; 128 (Pt 1)():206-12. PubMed ID: 6578068
    [Abstract] [Full Text] [Related]

  • 25. Experiments on the role of virus infections in the pathogenesis of bronchial asthma. The role of innate or acquired insufficiency or ergotropic adaptation in the mechanism of genesis of bronchial asthma.
    Filipp G.
    Allergol Immunopathol (Madr); 1976 Nov; 4(1):15-28. PubMed ID: 4969
    [Abstract] [Full Text] [Related]

  • 26. Reduced granulocyte response to isoproterenol, histamine, and prostaglandin E1 after in vitro incubation with Rhinovirus 16.
    Busse WW, Anderson CL, Dick EC, Warshauer D.
    Am Rev Respir Dis; 1980 Oct; 122(4):641-6. PubMed ID: 6254414
    [Abstract] [Full Text] [Related]

  • 27. Subnormal inhibition of active E rosette formation by isoproterenol in bronchial asthma.
    Lee CF, Han SH.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Jun; 13(2):128-37. PubMed ID: 6256132
    [Abstract] [Full Text] [Related]

  • 28. Mediators and non-specific bronchial hyperreactivity.
    Pauwels R.
    Eur J Respir Dis Suppl; 1983 Jun; 129():95-111. PubMed ID: 6360702
    [Abstract] [Full Text] [Related]

  • 29. Airway smooth muscle as a target of glucocorticoid action in the treatment of asthma.
    Hirst SJ, Lee TH.
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 3):S201-6. PubMed ID: 9817746
    [Abstract] [Full Text] [Related]

  • 30. [Bronchial hyperreactivity. I. General concepts].
    Zanotto CE, Boner AL.
    Pediatr Med Chir; 1985 Nov; 7(3):375-81. PubMed ID: 3837200
    [Abstract] [Full Text] [Related]

  • 31. Szentivanyi's hypothesis of asthma.
    Svedmyr N.
    Eur J Respir Dis Suppl; 1984 Nov; 136():59-65. PubMed ID: 6145619
    [No Abstract] [Full Text] [Related]

  • 32. Agonist-independent alteration in beta-adrenoceptor-G-protein-adenylate cyclase system in an equine model of recurrent airway obstruction.
    Abraham G, Kottke C, Dhein S, Ungemach FR.
    Pulm Pharmacol Ther; 2006 Nov; 19(3):218-29. PubMed ID: 16084121
    [Abstract] [Full Text] [Related]

  • 33. Interactions between beta-adrenergic activity and prostaglandin synthesis in control of airways bronchoconstrictor responsiveness.
    Walters EH.
    Agents Actions Suppl; 1983 Nov; 13():189-93. PubMed ID: 6307019
    [No Abstract] [Full Text] [Related]

  • 34. [Etiopathogenetic aspects of juvenile bronchial asthma. Mechanisms and mediators. II].
    Târdea A.
    Rev Pediatr Obstet Ginecol Pediatr; 1985 Nov; 34(3):233-48. PubMed ID: 2997899
    [No Abstract] [Full Text] [Related]

  • 35. Pharmacological modulation of bronchial hyperreactivity.
    Richards IM.
    Eur J Respir Dis Suppl; 1983 Nov; 129():148-76. PubMed ID: 6418560
    [Abstract] [Full Text] [Related]

  • 36. Receptors in asthmatic airways.
    Goldie RG.
    Am Rev Respir Dis; 1990 Mar; 141(3 Pt 2):S151-6. PubMed ID: 2155564
    [Abstract] [Full Text] [Related]

  • 37. Bronchial responsiveness to inhaled histamine and isoprenaline in patients with airway obstruction.
    Benson MK.
    Thorax; 1978 Apr; 33(2):211-3. PubMed ID: 663881
    [Abstract] [Full Text] [Related]

  • 38. Potential role for phenotypic modulation of bronchial smooth muscle cells in chronic asthma.
    Halayko AJ, Stephens NL.
    Can J Physiol Pharmacol; 1994 Nov; 72(11):1448-57. PubMed ID: 7767892
    [Abstract] [Full Text] [Related]

  • 39. Enhanced IgE-dependent basophil histamine release and airway reactivity in asthma.
    Gaddy JN, Busse WW.
    Am Rev Respir Dis; 1986 Nov; 134(5):969-74. PubMed ID: 3096179
    [Abstract] [Full Text] [Related]

  • 40. Acute respiratory infection, influenza vaccination and airway reactivity in asthma.
    Kava T.
    Eur J Respir Dis Suppl; 1987 Nov; 150():1-38. PubMed ID: 3480232
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.